Stents, statins, and other dumb luck.
作者信息
Robbins Phil
机构信息
Department of Molecular and Cell Biology, Henry M. Goldman School of Dental Medicine, Boston University, Boston, Massachusetts 02118, USA.
出版信息
J Biol Chem. 2011 Jan 21;286(3):1669-74. doi: 10.1074/jbc.X110.205633. Epub 2010 Nov 23.
Abstract
摘要
相似文献
1
Stents, statins, and other dumb luck.支架、他汀类药物，以及其他的意外好运。
J Biol Chem. 2011 Jan 21;286(3):1669-74. doi: 10.1074/jbc.X110.205633. Epub 2010 Nov 23.
2
Goals of statin therapy: three viewpoints. 2002.他汀类药物治疗的目标：三种观点。2002年。
Atheroscler Suppl. 2004 Oct;5(3):107-14. doi: 10.1016/j.atherosclerosissup.2004.08.031.
3
Stents and statins: history, clinical outcomes and mechanisms.支架与他汀类药物：历史、临床疗效及作用机制
Expert Rev Cardiovasc Ther. 2010 Sep;8(9):1283-95. doi: 10.1586/erc.10.113.
4
History of the cholesterol controversy in Britain.英国胆固醇争议的历史。
QJM. 2009 Feb;102(2):81-6. doi: 10.1093/qjmed/hcn158. Epub 2008 Nov 28.
5
A historical perspective on the discovery of statins.他汀类药物发现的历史透视
Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(5):484-93. doi: 10.2183/pjab.86.484.
6
A conversation with P. Roy Vagelos. Interview by Ushma S. Neill.与P. 罗伊·瓦格洛斯的对话。由乌什马·S·尼尔采访。
J Clin Invest. 2014 Jun;124(6):2291-2. doi: 10.1172/JCI76755. Epub 2014 Jun 2.
7
The statins in preventive cardiology.预防心脏病学中的他汀类药物。
N Engl J Med. 2008 Oct 2;359(14):1426-7. doi: 10.1056/NEJMp0806479.
8
The discovery of statins.他汀类药物的发现。
Cell. 2008 Sep 19;134(6):903-5. doi: 10.1016/j.cell.2008.09.008.
9
[About the discovery of hypolipidemic drugs].[关于降血脂药物的发现]
Med Clin (Barc). 2008 May 17;130(18):698-703. doi: 10.1157/13120774.
10
Thirty Years of Statins, Festschrift in honor of Dr. Akira Endo.
Atheroscler Suppl. 2004 Oct;5(3):1-130. doi: 10.1016/j.atherosclerosissup.2004.08.019.
本文引用的文献
1
The diversity of dolichol-linked precursors to Asn-linked glycans likely results from secondary loss of sets of glycosyltransferases.多萜醇连接的天冬酰胺连接聚糖前体的多样性可能源于糖基转移酶组的二次丢失。
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1548-53. doi: 10.1073/pnas.0409460102. Epub 2005 Jan 21.
2
Studies on the chemical basis of the phage conversion of O-antigens in the E-group Salmonellae.E群沙门氏菌中O抗原噬菌体转化的化学基础研究。
Biochemistry. 1962 Mar;1:323-35. doi: 10.1021/bi00908a020.
3
Separation of the two enzymatic phases in active sulfate synthesis.活性硫酸盐合成中两个酶促阶段的分离。
J Biol Chem. 1958 Sep;233(3):681-5.
4
The biosynthesis of chloramphenicol. II. Acetylation of p-nitrophenylserinol.氯霉素的生物合成。II. 对硝基苯基丝氨醇的乙酰化作用。
J Bacteriol. 1956 Aug;72(2):153-6. doi: 10.1128/jb.72.2.153-156.1956.
5
The gene cluster for chloramphenicol biosynthesis in Streptomyces venezuelae ISP5230 includes novel shikimate pathway homologues and a monomodular non-ribosomal peptide synthetase gene.委内瑞拉链霉菌ISP5230中氯霉素生物合成的基因簇包括新型莽草酸途径同源物和一个单模块非核糖体肽合成酶基因。
Microbiology (Reading). 2001 Oct;147(Pt 10):2817-2829. doi: 10.1099/00221287-147-10-2817.
6
A multigene family related to chitin synthase genes of yeast in the opportunistic pathogen Aspergillus fumigatus.在机会致病性真菌烟曲霉中，一个与酵母几丁质合酶基因相关的多基因家族。
Mol Gen Genet. 1995 Feb 6;246(3):353-9. doi: 10.1007/BF00288608.
7
Yeast mutants deficient in protein glycosylation.缺乏蛋白质糖基化的酵母突变体。
Proc Natl Acad Sci U S A. 1983 Dec;80(24):7466-70. doi: 10.1073/pnas.80.24.7466.
8
Direction of chain growth in polysaccharide synthesis.多糖合成中链增长的方向。
Science. 1967 Dec 22;158(3808):1536-42. doi: 10.1126/science.158.3808.1536.
9
Evidence for an intermediate stage in the biosynthesis of the Salmonella O-antigen.沙门氏菌O抗原生物合成中间阶段的证据。
Proc Natl Acad Sci U S A. 1965 Jul;54(1):235-41. doi: 10.1073/pnas.54.1.235.
10
Characterization of a polyisoprenoid compound functional in O-antigen biosynthesis.一种在O抗原生物合成中起作用的聚异戊二烯化合物的表征。
Proc Natl Acad Sci U S A. 1967 Jun;57(6):1798-803. doi: 10.1073/pnas.57.6.1798.
Zotero 插件